Pharmacological Management of Orthostatic Hypotension

Conclusions

There is limited evidence as to the benefits of pharmacological agents for treatment of OH, with only midodrine and fludrocortisone potentially being of use. Well-designed double-blind, randomised controlled trials comparing different drug options (and dosages) in the treatment of OH and symptom relief need to be conducted. Ideally, this should be done in combination with non-pharmaceutical interventions.